These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 18424188)

  • 1. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
    Prinz M; Schmidt H; Mildner A; Knobeloch KP; Hanisch UK; Raasch J; Merkler D; Detje C; Gutcher I; Mages J; Lang R; Martin R; Gold R; Becher B; Brück W; Kalinke U
    Immunity; 2008 May; 28(5):675-86. PubMed ID: 18424188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 interferons cool the inflamed brain.
    Axtell RC; Steinman L
    Immunity; 2008 May; 28(5):600-2. PubMed ID: 18482563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
    Gyülvészi G; Haak S; Becher B
    Eur J Immunol; 2009 Jul; 39(7):1864-9. PubMed ID: 19544494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system.
    Na SY; Cao Y; Toben C; Nitschke L; Stadelmann C; Gold R; Schimpl A; Hünig T
    Brain; 2008 Sep; 131(Pt 9):2353-65. PubMed ID: 18669487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant.
    Schmidt H; Raasch J; Merkler D; Klinker F; Krauss S; Brück W; Prinz M
    Exp Neurol; 2009 Apr; 216(2):306-11. PubMed ID: 19121307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulation of CNS-specific effector and regulatory T cells during tolerance induction by recombinant invariant chains in vivo.
    Lange C; Doster H; Steinbach K; Kalbacher H; Scholl M; Melms A; Bischof F
    Brain Behav Immun; 2009 Aug; 23(6):861-7. PubMed ID: 19362139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.
    Kavrochorianou N; Evangelidou M; Markogiannaki M; Tovey M; Thyphronitis G; Haralambous S
    J Leukoc Biol; 2016 Jan; 99(1):175-88. PubMed ID: 26232452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local type I IFN receptor signaling protects against virus spread within the central nervous system.
    Detje CN; Meyer T; Schmidt H; Kreuz D; Rose JK; Bechmann I; Prinz M; Kalinke U
    J Immunol; 2009 Feb; 182(4):2297-304. PubMed ID: 19201884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
    van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
    J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells.
    Kruglov AA; Lampropoulou V; Fillatreau S; Nedospasov SA
    J Immunol; 2011 Dec; 187(11):5660-70. PubMed ID: 22058414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon response in the central nervous system.
    Paul S; Ricour C; Sommereyns C; Sorgeloos F; Michiels T
    Biochimie; 2007; 89(6-7):770-8. PubMed ID: 17408841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
    Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T
    Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
    Ponomarev ED; Shriver LP; Maresz K; Dittel BN
    J Neurosci Res; 2005 Aug; 81(3):374-89. PubMed ID: 15959904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T; Mitsdoerffer M; Kuchroo VK
    Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
    Miller SD; McMahon EJ; Schreiner B; Bailey SL
    Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions.
    Ifergan I; Kebir H; Terouz S; Alvarez JI; Lécuyer MA; Gendron S; Bourbonnière L; Dunay IR; Bouthillier A; Moumdjian R; Fontana A; Haqqani A; Klopstein A; Prinz M; López-Vales R; Birchler T; Prat A
    Ann Neurol; 2011 Nov; 70(5):751-63. PubMed ID: 22162058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
    PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis.
    Piccio L; Buonsanti C; Mariani M; Cella M; Gilfillan S; Cross AH; Colonna M; Panina-Bordignon P
    Eur J Immunol; 2007 May; 37(5):1290-301. PubMed ID: 17407101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.